Cargando…

Leveraging real-world data to investigate multiple sclerosis disease behavior, prognosis, and treatment

Randomized controlled clinical trials and real-world observational studies provide complementary information but with different validity. Some clinical questions (disease behavior, prognosis, validation of outcome measures, comparative effectiveness, and long-term safety of therapies) are often bett...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cohen, Jeffrey A, Trojano, Maria, Mowry, Ellen M, Uitdehaag, Bernard MJ, Reingold, Stephen C, Marrie, Ruth Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Future Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950891/ https://www.ncbi.nlm.nih.gov/pubmed/31778094 http://dx.doi.org/10.1177/1352458519892555

Ejemplares similares

The Barancik lecture: Comorbidity in multiple sclerosis—Looking backward, looking forward
por: Marrie, Ruth Ann
Publicado: (2023)

Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
por: Walton, Clare, et al.
Publicado: (2020)

Pathways to cures for multiple sclerosis: A research roadmap
por: Bebo, Bruce F, et al.
Publicado: (2022)

Wellness and multiple sclerosis: The National MS Society establishes a Wellness Research Working Group and research priorities
por: Motl, Robert W, et al.
Publicado: (2017)

Recommendations for cognitive screening and management in multiple sclerosis care
por: Kalb, Rosalind, et al.
Publicado: (2018)

Do the current MS clinical course descriptors need to change and if so how? A survey of the MS community
por: Thompson, Alan J, et al.
Publicado: (2023)

COVID-19 in people with multiple sclerosis: A global data sharing initiative
por: Peeters, Liesbet M, et al.
Publicado: (2020)

Prioritizing progressive MS rehabilitation research: A call from the International Progressive MS Alliance
por: Zackowski, Kathleen M, et al.
Publicado: (2021)

Serotonin: A mediator of the gut–brain axis in multiple sclerosis
por: Malinova, Tsveta S, et al.
Publicado: (2017)

Recommendations for the use of propensity score methods in multiple sclerosis research
por: Simoneau, Gabrielle, et al.
Publicado: (2022)

Ethical use of off-label disease-modifying therapies for multiple sclerosis
por: Laurson-Doube, Joanna, et al.
Publicado: (2021)

Charting a global research strategy for progressive MS—An international progressive MS Alliance proposal
por: Thompson, Alan J, et al.
Publicado: (2021)

Exercise and lifestyle physical activity recommendations for people with multiple sclerosis throughout the disease course
por: Kalb, Rosalind, et al.
Publicado: (2020)

Placebo-controlled study in neuromyelitis optica—Ethical and design considerations
por: Cree, Bruce AC, et al.
Publicado: (2015)

The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

A systematic review of the incidence and prevalence of cancer in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

The challenge of comorbidity in clinical trials for multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Landscape of MS patient cohorts and registries: Recommendations for maximizing impact
por: Bebo, Bruce F, et al.
Publicado: (2017)

Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach—perspectives from the International Progressive MS Alliance
por: Zaratin, Paola, et al.
Publicado: (2022)

The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: A systematic review
por: Marrie, Ruth Ann, et al.
Publicado: (2015)

Recommendations for observational studies of comorbidity in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

WORLD CONFERENCE ON INDIAN SYSTEMS OF MEDICINE: AYU 2012
por: Ubale, Sandeep
Publicado: (2011)

Assessing kidney stone composition using smartphone microscopy and deep neural networks
por: Onal, Ege Gungor, et al.
Publicado: (2022)

Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art Review
por: Talasaz, Azita H., et al.
Publicado: (2021)

Multiple sclerosis disease-modifying drug use by immigrants: a real-world study
por: Graf, Jonas, et al.
Publicado: (2023)

Real-World Evidence for Equality
por: Johnson, C. Erwin, et al.
Publicado: (2021)

Leveraging the national cyberinfrastructure for biomedical research
por: LeDuc, Richard, et al.
Publicado: (2014)

Building Research Support Capacity across Human Health Biobanks during the COVID-19 Pandemic
por: Byrne, Jennifer A, et al.
Publicado: (2021)

Moving with the Times: The Health Science Alliance (HSA) Biobank, Pathway to Sustainability
por: Quinn, Carmel M, et al.
Publicado: (2021)

Mind Over Matter: Confronting Challenges in Post-Mortem Brain Biobanking for Glioblastoma Multiforme
por: Griffin, Cassandra, et al.
Publicado: (2021)

What is Kindness in Science and why does it matter?
por: Boulter, Jessica, et al.
Publicado: (2022)

Measuring and Leveraging Motives and Values in Dietary Interventions
por: Eustis, Sarah J., et al.
Publicado: (2021)

Smog, Cognition and Real-World Decision-Making
por: Chen, Xi
Publicado: (2018)

Leveraging Genetics to Advance Type 2 Diabetes Prevention
por: Florez, Jose C.
Publicado: (2016)

Antimicrobial Stewardship: Leveraging the “Butterfly Effect” of Hand Hygiene
por: Brink, Adrian John, et al.
Publicado: (2022)

Using real-world accelerometry-derived diurnal patterns of physical activity to evaluate disability in multiple sclerosis
por: Keller, Jennifer L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9g0rv0v23apb0ff6bfgf8ub6ut